Bacterial Infection Testing System

The system has been cleared by the U.S. Food and Drug Administration (FDA).

The increase in bacterial resistance is a challenge to even the most-effective antibiotics, and identifying resistance as early as possible allows for the use of active measures and therapeutic adjustments. This helps to prevent treatment failures and reduces emerging resistance, states bioMerieux, S.A. (Marcy l'Etoile, France), the developer of Vitek 2 Compact.

Using multi-spectrum colorimetric and transmittance optic systems, the Vitek 2 Compact detects changes in organism growth under various media and antibiotic concentrations. The system's analysis algorithm then interprets these readings to provide rapid, accurate translation into microorganism identification and susceptibility results. The Viteck 2 Compact is built on the same proven technology as the Vitek 2 but with a smaller footprint. The Vitek 2 Compact was introduced at the annual meeting of the American Society for Microbiology in Atlanta (GA, USA) in June 2005.

"The most important task facing the microbiology laboratory is reporting rapid, accurate, and clinically relevant results,” said Herb Steward, senior vice president, North American commercial operations of bioMerieux. "Accurate microbial detection is the first step in achieving this goal, and the Vitek 2 Compact can now provide the same rapid results to small and mid-sized labs using the same market-leading technology of our Viteck 2.”




Related Links:
bioMerieux